The new anti – COVID drug 2 – DG: How it is working?

New anti – COVID drug 2DG (2-deoxy-D-glucose)

New anti – COVID drug 2DG (2-deoxy-D-glucose) is developed by India. Ministry announced that it may cost INR 500-600/-. This new anti – COVID drug is approved by DGCI (Drugs Controller General of INDIA) to use in emergency situations for COVID-19 patients.  This is developed by DRDO.

This is the oral anti – COVID drug, it will quicken the recovery of COVID-19 patients who are hospitalized. As COVID -19 second wave hits India vigorously, now India in need of expedited recovery from COVID – 19.

India is facing a huge Oxygen crisis, this new anti – COVID drug will help patients to reduce their dependency on medical oxygen and it has no side effects. The Ministry of India announced that this new anti – COVID drug will be available on the market within a week. Here we will discuss the experts’ words about the new anti – COVID drug 2-deoxy-D-glucose (2DG) and its working…

Why anti – COVID drug is approved?

This new anti – COVID drug is an oral supplement, developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO in collaboration with Dr. Reddy’s Laboratories, Hyderabad. As many scientists creating confusion, by stating about plasma, REMDESIVIR treatments are not much effective.

People questioning why the new anti – COVID drug 2 DG is preferable for the emergency need of COVID 19 patients. Researches say that 2-deoxy-D-glucose and D-glucose act as antiviral and chemotherapy agents. This 2-deoxy-D-glucose is a well-known anti-metabolite in CANCER cells.

It has the ability to enchanting the therapeutic efficacy of radiation and chemotherapies against various tumors. According to the reports in 2012, it protects cells from oxidative stress it is proven the best medicine for breast cancer and it weakens the cells quickly.  So it gets approval from the ICMR to utilize it as the emergency drug for COVID – 19 patients.

How to intake the anti – COVID drug?

This drug released as trial sample sachets. By dissolving this powdered drug in water, then this is ready to serve orally for a COVID patient under the physician’s prescription. DRDO announced that after the completion of 3rd trial on volunteer patients, the new anti – COVID drug 2-deoxy-D-glucose (2DG) will be served as an emergency drug for COVID patients. Later It will come in the form of tablets.

How an anti – COVID drug works?

This 2-deoxy-D-glucose will cumulate the corona-infected cells and restricts their growth by terminating the viral energy and synthesis. The ministry explained, “this is the unique drug which selectively cumulates the virus-infected cells”.

What’s more about anti – COVID drug?

As the ministry stated that this is a unique drug, 2-deoxy-D-glucose assists the patients by stabilizing their oxygen levels without medical oxygen supplements, after the third day of drug usage. This drug proven its uniqueness in its first sample trial.

This shows there is a faster relief from oxygen therapy by intake of this 2-deoxy-D-glucose (2 DG).

By the COVID-19 second wave effect, India is facing many critical challenges, insufficient beds at hospitals, and a shortage of oxygen supply. But this anti – COVID drug will reduce the stay of a patient hospital after, continuous medication of a week.

By strengthening the oxygen levels of the patients and reducing the virus-infected cell’s strength, patients will recover quickly from the virus infection with this drug.